Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved EPKINLY or epcoritamab, for the treatment of ...
2-Year U.S. Treasury Note Continuous Contract $102.766 0.027 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.461 0.102 0.10% 10-Year U.S. Treasury Note Continuous Contract $109.094 0.141 ...
Western Midstream Partners L.P.-0.62% $15.74B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback